A novel treatment for "morning sickness": Nausea of pregnancy could be induced by excess sulfite which molybdenum can help alleviate.

Abstract

Nausea and vomiting of pregnancy (NVP) remains difficult to treat. Last century, thalidomide was used to alleviate NVP, but it caused teratogenesis by interfering with angiogenesis. The gasotransmitters hydrogen sulfide (H2S) and nitric oxide are mutually dependent on each other for their angiogenesis-related functions. Pregnancy-related requirements for increased endogenous H2S could create a temporary excess of sulfite, an H2S catabolite, which is toxic and can induce nausea. Sulfite oxidase, a molybdenum-containing enzyme, catalyzes oxidation of sulfite to sulfate, which can then be excreted or reused by the body. Supplementation with molybdenum should facilitate enhanced sulfite oxidase activity, thus lowering gestationally-elevated sulfite levels in the gastrointestinal tract and easing NVP.

• Authors: Catherine E Taylor
• Journal: Medical hypotheses (Med Hypotheses) Vol. 95 Pg. 31-33 (Oct 2016) ISSN: 1532-2777 [Electronic] United States
• PMID: 27692161 (Publication Type: Journal Article)
• Copyright: Copyright © 2016 Elsevier Ltd. All rights reserved.

Chemical References

• Sulfites
• Trace Elements
• Nitric Oxide
• Pyridoxal Phosphate
• Molybdenum
• Oxygen
• Hydrogen Sulfide

Topics

• Catalysis
• Female
• Humans
• Hydrogen Sulfide (chemistry)
• Models, Theoretical
• Molybdenum (therapeutic use)
• Morning Sickness (therapy)
• Nausea (therapy)
• Neovascularization, Pathologic
• Nitric Oxide (chemistry)
• Oxygen (chemistry)
• Pregnancy
• Pyridoxal Phosphate (chemistry)
• Sulfites (adverse effects, chemistry)
• Trace Elements